Sino-UK partnership for patients

By Ding Yining | April 12, 2016, Tuesday |

Online Edition

British pharmaceutical giant AstraZeneca and Beijing-based mobile healthcare consultation application Chunyu Doctor said they have formed a partnership to offer patients with management of chronicle diseases.

The two parties would focus on patients’ medical and daily demand for care of cardiovascular diseases and diabetes with the number of patients for these two disease areas rises quickly.

They would launch joint training activities for grass-root medical practitioners as well as patient education programs both through online and offline channels so that patients can have better understanding of their health situation.

Patients that are diagnosed with cardiovascular diseases not only want to receive prescription from doctors, but also their instruction and guidance regarding their daily activities such as dietary habits, according to Wang Lei, president of AstraZeneca China.

“The partnership would enhance patients’ disease management capabilities as they can leverage Chunyu Doctor’s online platform for disease consultation and follow-up visits with doctors and is also our latest efforts to respond to the national healthcare reform,” said Chunyu Doctor’s founder and chief executive officer Zhang Rui.

Chunyu said it currently connects with more than 90 million users and about 400,000 physicians across the country so that patients can consult health problems, mainly mild ones, through online channels instead of going to hospitals.

Business

About Us
|
Terms of Use
|
RSS
|
Privacy Policy
|
Contact Us
|
Shanghai Call Center: 962288
|
Tip-off hotline: 52920043

沪ICP证：沪ICP备05050403号-1
|
互联网新闻信息服务许可证：31120180004
|
网络视听许可证：0909346
|
广播电视节目制作许可证：沪字第354号
|
增值电信业务经营许可证：沪B2-20120012

Sino-UK partnership for patients

Email this to your friend